Atomoxetine is a CNS stimulant class medication that is used to treat attention deficit hyperactivity disorder, depression, fibromyalgia, and social anxiety. Suppliers of atomoxetine medications market it in the form of 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg capsules. The main alternatives to atomoxetine are other CNS stimulants, such as methylphenidate, dextroamphetamine, and lisdexamfetamine. Atomoxetine differs in the mechanism of action compared to these medications, which are all associated with increased side-effects and risk of dependency. Consequently, atomoxetine can be said to have a superior safety profile to these substitute drugs. Following FDA approval for medical use in 2002, the earliest atomoxetine manufacturer and patent-filing company Eli Lilly began marketing the drug under the trade name Strattera. The producer’s patent, however, expired in 2010, paving the way for other manufacturers and atomoxetine suppliers. Companies Sandoz, Mylan, Teva, Greenstone, and Sun Pharma have since introduced their atomoxetine medications into the global pharmaceutical market. The drug has gained popularity throughout the years and has become widely prescribed, with over 2 million prescriptions registered yearly in the U.S. alone. Consequently, atomoxetine suppliers and distributors currently market both generic and trade name formulations of the drug.

Atomoxetine is known to be a potent and selective inhibitor of the norepinephrine transporter (NET), which prevents cellular reuptake of norepinephrine throughout the brain, which is thought to improve the symptoms of ADHD. More recently, positron emission tomography (PET) imaging studies in rhesus monkeys have shown that atomoxetine also binds to the serotonin transporter (SERT),9 and blocks the N-methyl-d-aspartate (NMDA) receptor,10 indicating a role for the glutamatergic system in the pathophysiology of ADHD. The pharmacokinetic profile of atomoxetine is highly dependent on cytochrome P450 2D6 genetic polymorphisms of the individual. A large fraction of the population (up to 10% of Caucasians and 2% of people of African descent and 1% of Asians) are poor metabolizers (PMs) of CYP2D6 metabolized drugs. These individuals have reduced activity in this pathway resulting in 10-fold higher AUCs, 5-fold higher peak plasma concentrations, and slower elimination of atomoxetine compared with people with normal CYP2D6 activity.

Based on the drugstore you go to, a 30-capsule prescription of atomoxetine oral capsule 25 mg costs about $117. Costs of Atomoxetine vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. Atomoxetine is available for sale from various Atomoxetine vendors at multiple costs. Prices are applicable just for cash consumers and do not apply to insurance policies. Atomoxetine suppliers, on the whole, are in favor of patient aid initiatives. This cost may differ among dealers.

Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Atomoxetine manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. PipelinePharma is the most reliable source for this medication. Finding an honest partner in our business is one of the significant challenges. To overcome this challenge and make one's life easier when looking for a direct manufacturer and supplier of Atomoxetine, one can go to the Pipelinepharma website, which assists buyers in locating dependable manufacturers and suppliers of Atomoxetine.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Atomoxetine offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Atomoxetine suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Atomoxetine. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Atomoxetine is already registered. Manufacturers also have special delivery terms.

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Atomoxetine suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Atomoxetine manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.